![Gary Ingenito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Ingenito
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 30.06.2026
Profil
Dr. Gary Ingenito was previously employed as a Chief Medical & Regulatory Officer by Catalyst Pharmaceuticals, Inc., a Chief Clinical & Regulatory Affairs Officer by Angiotech Pharmaceuticals, Inc., a Senior Vice President by Pharmanet Development Group, Inc., a Head-Regulatory Affairs by Boehringer Ingelheim Pharmaceuticals, Inc., a Senior Vice President-Scientific Affairs by Ontrak, Inc., and a Head-Medical Affairs by Sandoz Pharmaceuticals Corp.
He received his undergraduate degree from The Johns Hopkins University, a graduate degree from the University of Miami, a doctorate degree from Sidney Kimmel Medical College and a doctorate degree from Thomas Jefferson University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2025 | 68’873 ( 0.06% ) | 2 Mio $ | 30.06.2026 |
Ehemalige bekannte Positionen von Gary Ingenito
| Unternehmen | Position | Ende |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2025 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Technik-/Wissenschafts-/F&E-Leiter | 29.02.2008 |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Corporate Officer/Principal | 01.01.2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | General Counsel | - |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Ausbildung von Gary Ingenito
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
Ontrak, Inc.
 Ontrak, Inc. Medical/Nursing ServicesHealth Services Provides behavioral healthcare services | Health Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Sidney Kimmel Medical College
 Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals Corp. |
